Carmela Abraham

Q: What Schools Are Affiliated With Carmela Abraham

Carmela Abraham is affiliated with the following schools: University of California, Berkeley, Boston University, Stanford University

Carmela Abraham's AcademicInfluence.com Rankings

Carmela Abraham

Biology

#7321

World Rank

#10224

Historical Rank

Neuroscience

#1109

World Rank

#1151

Historical Rank

biology Degrees

Download Badge

Biology

Carmela Abraham's Degrees

PhD Neuroscience Stanford University

Why Is Carmela Abraham Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Carmela R. Abraham is an American neuroscientist who focuses on the study of Alzheimer’s disease. Early life and education Abraham earned her Bachelor of Science degree in Biology from Tel Aviv University and her PhD in Neuroscience from Harvard University. In 1990, Abraham was the recipient of The Neuroscience Education and Research Foundation Award for an Outstanding Promise as a Young Alzheimer Investigator. She was also the first Rappaport Scholar at the Center for Neurologic Diseases at Brigham and Women’s Hospital, and the recipient of the Zenith and Temple awards from the Alzheimer’s Association.

(See a Problem?)

Carmela Abraham's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The spectrum of disease in chronic traumatic encephalopathy. (2013) (1695)
Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. (1993) (986)
Immunochemical identification of the serine protease inhibitor α 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease (1988) (874)
X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. (1986) (516)
Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17 (2007) (489)
Isolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's Disease (1986) (414)
Central nervous system damage produced by expression of the HIV-1 coat protein gpl20 in transgenic mice (1994) (393)
Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. (1994) (331)
Neurobiological Bases of Age-Related Cognitive Decline in the Rhesus Monkey (1996) (288)
Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice (1994) (288)
Antibodies to paired helical filaments in Alzheimer's disease do not recognize normal brain proteins (1983) (245)
Life extension factor klotho enhances cognition. (2014) (225)
Microtubule-associated protein 2: monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer neurofibrillary tangles. (1984) (222)
Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers. (1982) (210)
Increased microglial activation and protein nitration in white matter of the aging monkey☆ (1999) (205)
The Neuroprotective Effect of Klotho is Mediated via Regulation of Members of the Redox System* (2014) (165)
The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. (2003) (162)
α 1-Antichymotrypsin is associated solely with amyloid deposits containing the β-protein. Amyloid and cell localization of α 1-antichymotrypsin (1990) (146)
Life Extension Factor Klotho Prevents Mortality and Enhances Cognition in hAPP Transgenic Mice (2015) (143)
Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA. (1989) (141)
α1‐Antichymotrypsin Binding to Alzheimer Aβ Peptides Is Sequence Specific and Induces Fibril Disaggregation In Vitro (1993) (136)
Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease. (1997) (135)
The Antiaging Protein Klotho Enhances Oligodendrocyte Maturation and Myelination of the CNS (2013) (132)
Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice. (2000) (130)
Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo (1997) (125)
Gene profile analysis implicates Klotho as an important contributor to aging changes in brain white matter of the rhesus monkey (2008) (113)
Amyloid Precursor Protein Is Synthesized by Retinal Ganglion Cells, Rapidly Transported to the Optic Nerve Plasma Membrane and Nerve Terminals, and Metabolized (1993) (101)
Apolipoprotein E Is Synthesized in the Retina by Müller Glial Cells, Secreted into the Vitreous, and Rapidly Transported into the Optic Nerve by Retinal Ganglion Cells (*) (1996) (100)
Identification of Cleavage Sites Leading to the Shed Form of the Anti-Aging Protein Klotho (2014) (96)
Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein (1995) (93)
Metalloendopeptidase EC 3.4.24.15 Is Necessary for Alzheimer’s Amyloid-β Peptide Degradation* (1999) (92)
Lack of correlation between plaque burden and cognition in the aged monkey (1997) (90)
Promoter methylation and age-related downregulation of Klotho in rhesus monkey (2012) (89)
Age‐related molecular reorganization at the node of Ranvier (2006) (80)
Astrocytic hypertrophy and altered GFAP degradation with age in subcortical white matter of the rhesus monkey (2000) (80)
Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain (1997) (79)
Reactive astrocytes and α1-antichymotrypsin in Alzheimer’s disease ☆ ☆ Supported by the NIH and the Alzheimer’s Association. (2001) (70)
α1-Antichymotrypsin is present together with the β-protein in monkey brain amyloid deposits (1989) (66)
Visualization of APP dimerization and APP‐Notch2 heterodimerization in living cells using bimolecular fluorescence complementation (2006) (65)
Alzheimer's disease: Immunoreactivity of neurofibrillary tangles with anti-neurofilament and anti-paired helical filament antibodies (1984) (65)
Huntington's disease: Changes in striatal proteins reflect astrocytic gliosis (1982) (65)
Transplants of mouse trisomy 16 hippocampus provide a model of Alzheimer's disease neuropathology. (1991) (62)
A calcium-activated protease from Alzheimer's disease brain cleaves at the N-terminus of the amyloid beta-protein. (1991) (59)
Small-molecule Klotho enhancers as novel treatment of neurodegeneration. (2012) (59)
What’s Behind the Decline? The Role of White Matter in Brain Aging (2007) (59)
Alzheimer's Disease: Recent Advances in Understanding the Brain Amyloid Deposits (1989) (57)
Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide (2009) (55)
PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation (2014) (54)
Allele ϵ4 of Apolipoprotein E Shows a Dose Effect on Age at Onset of Pick Disease (1995) (52)
Klotho Is a Neuroprotective and Cognition-Enhancing Protein. (2016) (52)
Identification of novel small molecules that elevate Klotho expression. (2012) (51)
Identification of a metalloprotease from Alzheimer's disease brain able to degrade the beta-amyloid precursor protein and generate amyloidogenic fragments. (1994) (48)
Amyloid precursor protein interacts with notch receptors (2005) (46)
The Anti-Aging and Tumor Suppressor Protein Klotho Enhances Differentiation of a Human Oligodendrocytic Hybrid Cell Line (2014) (45)
Demonstration of plasma proteinase inhibitors in beta 2-microglobulin amyloid deposits. (1992) (44)
The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination (2015) (43)
Developmental expression of α1-antichymotrypsin in brain may be related to astrogliosis (1991) (43)
Reactive astrocytes and alpha1-antichymotrypsin in Alzheimer's disease. (2001) (43)
A calcium-stimulated serine protease from monkey brain degrades the β-amyloid precursor protein (1992) (43)
Age‐dependent accumulation of ubiquitinated 2′,3′‐cyclic nucleotide 3′‐phosphodiesterase in myelin lipid rafts (2008) (42)
The role of the acute-phase protein α1-antichymotrypsin in brain dysfunction and injury (1992) (39)
Association between bleomycin hydrolase and Alzheimer's disease in caucasians (1998) (39)
INVESTIGATION OF SILICON AND ALUMINUM CONTENT IN ISOLATED SENILE PLAQUE CORES BY LASER MICROPROBE MASS ANALYSIS (LAMMA) (1986) (37)
Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro. (1993) (37)
Activation of calpain‐1 in myelin and microglia in the white matter of the aged rhesus monkey (2004) (37)
Acyl peptide hydrolase, a serine proteinase isolated from conditioned medium of neuroblastoma cells, degrades the amyloid‐β peptide (2007) (35)
Serum paraoxonase activity is associated with variants in the PON gene cluster and risk of Alzheimer disease (2012) (35)
Biochemical and Functional Characterization of the Klotho-VS Polymorphism Implicated in Aging and Disease Risk* (2013) (33)
Activation of the Anti-Aging and Cognition-Enhancing Gene Klotho by CRISPR-dCas9 Transcriptional Effector Complex (2018) (32)
The Protease Inhibitor, α1-Antichymotrypsin, Is a Component of the Brain Amyloid Deposits in Normal Aging and Alzheimer's Disease (1989) (31)
Oxysterol-binding protein-1 (OSBP1) modulates processing and trafficking of the amyloid precursor protein (2008) (31)
MicroRNA-339 and microRNA-556 regulate Klotho expression in vitro (2014) (30)
Expression of cathepsin G-like and α1-antichymotrypsin-like proteins in reactive astrocytes (1993) (30)
Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin. (1990) (29)
α1‐Antichymotrypsin Inhibits Aβ Degradation in Vitro and in Vivo (2000) (29)
Activation of early components of complement targets myelin and oligodendrocytes in the aged rhesus monkey brain (2006) (28)
Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study (2019) (25)
Neutrophil proteases associated with amyloid fibrils. (1993) (25)
Isolation of paired helical filaments and amyloid fibers from human brain. (1986) (24)
Klotho Is Neuroprotective in the Superoxide Dismutase (SOD1G93A) Mouse Model of ALS (2019) (23)
Allele epsilon 4 of apolipoprotein E shows a dose effect on age at onset of Pick disease. (1995) (22)
α-1-Antichymotrypsin, a Serine Protease Inhibitor, is a Component of the Amyloid Deposits in Alzheimer’s Disease (1988) (21)
ASTROCYTES IN ALZHEIMER??S DISEASE GRAY MATTER EXPRESS ??1 ANTICHYMOTRYPSIN mRNA: 81 (1989) (20)
Blood brain barrier endothelial cells express candidate amyloid precursor protein-cleaving secretases. (1998) (20)
Alpha 1-antichymotrypsin inhibits A beta degradation in vitro and in vivo. (2000) (18)
α 1 á-Antichymotrypsin (1990) (18)
Tau Phosphorylation is Impacted by Rare AKAP9 Mutations Associated with Alzheimer Disease in African Americans (2018) (18)
Cell‐type dependent modulation of Notch signaling by the amyloid precursor protein (2010) (18)
Lowering of amyloid beta peptide production with a small molecule inhibitor of amyloid-β precursor protein dimerization. (2012) (17)
Klotho, PTSD, and advanced epigenetic age in cortical tissue (2020) (16)
The Role of Proteases and Their Inhibitors in the Amyloid Deposition of Alzheimer's Disease and Normal Brain Aging (1990) (15)
Monoclonal Antibodies Against the Human Metalloprotease EC 3.4.24.15 Label Neurofibrillary Tangles in Alzheimer's Disease Brain (1996) (15)
The protease inhibitor, alpha 1-antichymotrypsin, is a component of the brain amyloid deposits in normal aging and Alzheimer's disease. (1989) (14)
Synthesis and secretion of active α 1-Antichymotrypsin by murine primary astrocytes (1996) (14)
Developmental expression of alpha 1-antichymotrypsin in brain may be related to astrogliosis. (1991) (14)
Potential roles of protease inhibitors in Alzheimer's disease (1989) (13)
Klotho regulation by albuminuria is dependent on ATF3 and endoplasmic reticulum stress (2019) (13)
Alpha 1-antichymotrypsin in brain aging and disease. (1989) (13)
Purification and Cloning of Brain Proteases Capable of Degrading the β‐Amyloid Precursor Protein a (1992) (13)
Human endopeptidase (THOP1) is localized on chromosome 19 within the linkage region for the late-onset alzheimer disease AD2 locus. (1996) (13)
Comparable dimerization found in wildtype and familial Alzheimer's disease amyloid precursor protein mutants. (2013) (12)
Platelets and DAMI megakaryocytes possess β-secretase-like activity (1999) (12)
Candidate molecular pathways of white matter vulnerability in the brain of normal aging rhesus monkeys (2018) (11)
Alpha 1-antichymotrypsin is present together with the beta-protein in monkey brain amyloid deposits. (1989) (11)
A Novel Brain Cysteine Protease Forms an SDS Stable Complex with the β‐Amyloid Precursor Protein a (1996) (11)
Facile and sensitive assay for monitoring proteolytic activities with defined specificities: studies on amyloid beta-protein processing in Alzheimer's disease. (1990) (10)
Amyloid β-protein precursor and apolipoprotein E production in cultured cerebral endothelial cells isolated from brains of patients with neurodegenerative disorders at autopsy (1995) (10)
Synthesis and secretion of active alpha 1-antichymotrypsin by murine primary astrocytes. (1996) (10)
Expression of cathepsin G-like and alpha 1-antichymotrypsin-like proteins in reactive astrocytes. (1993) (9)
PTSD and the klotho longevity gene: Evaluation of longitudinal effects on inflammation via DNA methylation (2020) (9)
Identification of the cleavage sites leading to the shed forms of human and mouse anti-aging and cognition-enhancing protein Klotho (2020) (8)
SYNAPTIC ALTERATIONS IN THE CORTEX OF APP TRANSGENIC MICE (1993) (7)
Identification of full length β-amyloid precursor protein in human neuronal and non-neuronal cell culture supernatant: a possible extracellular source for the generation of Aβ (1994) (7)
Isolation of a 16 KD Fraction with Extremely High AEF Activity (1991) (6)
The role of the acute-phase protein alpha 1-antichymotrypsin in brain dysfunction and injury. (1992) (6)
Paired Helical Filaments in Human Neurons: Relationship to Neurofilaments (1985) (6)
The fibril forming region of the beta-amyloid precursor differs from that of the amyloid A precursor in its interaction with lipids. (1996) (6)
Alzheimerʼs disease: immunoreactivity of neurofibrillary tangles with anti-neurofilament and anti-paired helical filament antibodies (1987) (6)
Platelets and DAMI megakaryocytes possess beta-secretase-like activity. (1999) (6)
2014 annual meetings. (2014) (5)
A novel brain cysteine protease forms an SDS stable complex with the beta-amyloid precursor protein. (1996) (5)
Studies on the Proteolytic Degradation of the β‐Protein Precursor by Proteases Purified from Alzheimer's Disease Brain a (1991) (5)
Aging-suppressor Klotho: Prospects in diagnostics and therapeutics (2022) (5)
A Transgenic Model Reveals the Role of Klotho in Pancreatic Cancer Development and Paves the Way for New Klotho-Based Therapy (2021) (4)
105 ANTIBODIES TO THE FAIL TO REACT WITH NEUROFILAMENTS AND OTHER NORMAL PROTEINS (1983) (4)
Immunological fac tors in Alzheimer's diseas (1992) (4)
Identification of a novel serine protease-like molecule in human brain. (1998) (4)
Amyloid β peptide: A century of discoveries (2000) (4)
Small Molecule Amyloid-β Protein Precursor Processing Modulators Lower Amyloid-β Peptide Levels via cKit Signaling. (2019) (3)
A method to specifically activate the Klotho promoter by using zinc finger proteins constructed from modular building blocks and from naturally engineered Egr1 transcription factor backbone (2020) (3)
Purification and cloning of brain proteases capable of degrading the beta-amyloid precursor protein. (1992) (3)
AAV‐mediated expression of secreted and transmembrane αKlotho isoforms rescues relevant aging hallmarks in senescent SAMP8 mice (2022) (2)
X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-(3 conformation (2)
Genetic variation in PLXNA4 associated with susceptibility of Alzheimer’s disease through tau phosphorylation (2013) (2)
Biochemical and Structural Studies of Paired Helical Filaments and Senile Plaque Amyloid in Alzheimer’s Disease (1986) (2)
Biochemical and Structural Studies of Paired Helical Filaments and Senile Plaque Amyloid in Alzheimer’s Disease (1986) (2)
Amyloid Beta Peptide and the Amyloid Cascade Hypothesis (2011) (2)
Microtubule-associated protein 2: monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer neurofibrillary tangles (1987) (2)
PRODUCTION OF AMYLOID-SPECIFIC ANTIBODIES TO LOW MOLECULAR WEIGHT PROTEINS ISOLATED FROM ALZHEIMERʼS DISEASE (AD) BRAIN (1986) (2)
miR-142-3p Regulates Cortical Oligodendrocyte Gene Co-expression Networks Associated with Tauopathy. (2021) (2)
Molecular Properties of Paired Helical Filaments and Senile Plaque Amyloid Fibers in Alzheimer’s Disease (1986) (1)
Metalloendopeptidase EC 3.4.24.15 in Neurodegeneration (2002) (1)
BIOCHEMICAL ANALYSES OF SENILE PLAQUE AMYLOID CORES PURIFIED BY FLUORESCENCE ACTIVATED CELL SORTING (1985) (1)
Detection of amyloid-β protein precursor homo-interactions using beta-galactosidase enzyme fragment complementation. (2011) (1)
161 MONOCLONAL ANTIBODIES TO ALZHEIMER PAIRED HELICAL FILAMENTS PRODUCED BY RAT-MOUSE HYBRIDOMAS (1984) (1)
Chapter 751 – Acylaminoacyl-Peptidase (2013) (1)
Development of Klotho enhancers as novel therapeutics for Alzheimer's disease (2010) (1)
CROSSLINKING OF ALZHEIMER PAIRED HELICAL FILAMENTS: ANALOGIES TO TRANSGLUTAM-INASE-CATALYZED FILAMENT CROSSLINKING IN VITRO (1982) (1)
The Serpin, α1-Antichymotrypsin, in Brain Aging and Diseases of the Nervous System (1990) (1)
The identification of an Alzheimer's disease gene on chromosome 14 opens new avenues for research. The views of an amyloidologist (1995) (0)
Association of Circulating Fibroblast Growth Factor 23 with Incident Dementia: The Framingham Heart Study (S48.004) (2018) (0)
Proteolytic Processing of β-Protein Precursor-Related Synthetic Peptides (1990) (0)
O1-03-07: Klotho, aging and Alzheimer's (2008) (0)
Purification and cloning of monkey proteases involved in the processing of the β-amyloid precursor protein (1993) (0)
Small heat shock protein αB‐crystallin potentiates Aβ neurotoxicity by hetero‐oligomeric stabilization (2021) (0)
A NOVEL BRAIN CYSTEINE PROTEASE IS CAPABLE OF PROCESSING THE B AMYLOID PRECURSOR PROTEIN: 4 (1995) (0)
The Anti-Aging and Tumor Suppressor Protein Klotho Enhances Differentiation of a Human Oligodendrocytic Hybrid Cell Line (2014) (0)
Tau Phosphorylation is Impacted by Rare AKAP9 Mutations Associated with Alzheimer Disease in African Americans (2018) (0)
Bleomycin hydrolase alters amyloid precursor protein trafficking, aβsecretion and the Aβ42/Aβ40 ratio in a dose dependent manner (2000) (0)
aB-Crystallin expression in Alzheimer’s Disease brain in neuritic and diffuse plaques (2016) (0)
The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination (2015) (0)
αB-Crystallin interaction with Alzheimer’s Disease Amyloid-β potentiates Aβ-Mediated Neurotoxicity (2015) (0)
Amyloid precursor protein binding partners in human embryonic kidney 293 cells (2000) (0)
269 Lack of correlation between plaque burden and cognition in the aging monkey (1996) (0)
P2-362: Detection of amyloid precursor protein dimerization in cells using enzyme fragment complementation and bimolecular fluorescent complementation (2008) (0)
Klotho gene protects primary hippocampal neurons from oxidative stress (2013) (0)
αB-Crystallin Modulates Amyloid-β toxicity and impairs Synaptic Transmission (2014) (0)
337 Metalloendopeptidase E.C.3.4.24.15 and Alzheimer's disease (1996) (0)
Amyloidogenic effects of α1-antichymotrypsin in vitro and in vivo (2000) (0)
Differential toxicity profile of secreted and processed α-Klotho expression over mineral metabolism and bone microstructure (2023) (0)
Symposium S10: Degradation and Repair of Myelin: Role of Proteases and Complement (2004) (0)
THE ANTI-AGING PROTEIN KLOTHO ENHANCES OLIGODENDROCYTE MATURATION AND MYELINATION OF THE CENTRAL NERVOUS SYSTEM (2013) (0)
Alzheimer's and Parkinson's disease: anatomical, pathological and biochemical aspects (1986) (0)
Activation of the Anti-Aging and Cognition-Enhancing Gene Klotho by CRISPR-dCas9 Transcriptional Effector Complex (2018) (0)
αB-Crystallin secretion from astrocytes and its implications for Alzheimer’s Disease (2013) (0)
P4-077 Modulation of amyloid precursor protein-processing by oxysterol-binding protein (2006) (0)
Amyloid beta peptide: a century of discoveries. (2000) (0)
Dose effect of allele {epsilon}4 of apolipoprotein E on risk and age at onset of Pick disease (1994) (0)
The functions of the anti-aging protein Klotho in the brain (2010) (0)
P4-002 Bimolecular fluorescence complementation studies of APP homodimerization and heterodimerization (2006) (0)
P4-186: Modulating Klotho expression to protect against age-induced neurodegeneration (2008) (0)
[Alzheimer's disease and the significance of amyloid-beta protein in its pathogenesis]. (1995) (0)
Promoter methylation and age-related downregulation of Klotho in rhesus monkey (2011) (0)
Candidate molecular pathways of white matter vulnerability in the brain of normal aging rhesus monkeys (2018) (0)
MicroRNA-339 and microRNA-556 regulate Klotho expression in vitro (2013) (0)
HPLC Analysis of Proteins from Alzheimer Paired Helical Filaments (1987) (0)
Hypothesis: β amyloid precursor protein is a key sorting and targeting receptor for neuropeptidases (1997) (0)
α1-ANTICHYMOTRYPSIN IN BRAIN AGING AND DISEASE (1988) (0)
Impact and blast neurotrauma mouse models of chronic traumatic encephalopathy validated by human neuropathology (2013) (0)
THE EFFECTS OF APOLIPOPROTEIN E AND Aβ ON THE VIABILITY OF CULTURED MOUSE HIPPOCAMPAL NEURONS: 3 (1995) (0)
P1-201 In search for APP-binding proteins (2004) (0)
COMPONENT OF THE AMYLOID DEPOSITS IN ALZHEIMER'S DISEASE (1988) (0)
A NOVEL CALCIUM-DEPENDENT SERINE PROTEASE FROM BRAIN CLEAVES β-PROTEIN-RELATED SYNTHETIC PEPTIDES AND IS INHIBITED BY α-ANTICHYMOTRYPSIN AND PROTEASE NEXIN 2: 217 (1990) (0)
Proteolytic Processing of ß-Amyloid Protein-Related Synthetic Peptides and the ß-Protein Precursor by a Protease Purified from Alzheimer’s Disease Brain (1991) (0)
Specific cleavage and nuclear localization of metalloendopeptidase EC3.4.24.15 (2000) (0)
Table of Contents (1991) (0)
TAU PHOSPHORYLATION IS IMPACTED BY RARE AD-ASSOCIATED AKAP9 MUTATIONS SPECIFIC TO AFRICAN AMERICANS (2017) (0)

This paper list is powered by the following services:

Other Resources About Carmela Abraham

en.wikipedia.org

What Schools Are Affiliated With Carmela Abraham?

Carmela Abraham is affiliated with the following schools:

Carmela Abraham's Academic­Influence.com Rankings